APO Research
Talk to an analyst

APO RESEARCH · REPORT

TROP2-ADC Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global TROP2-ADC Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025194 pages

Choose your research edition.

Industry ResearchTROP2-ADC Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal TROP2-ADC Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal TROP2-ADC Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TROP2-ADC Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal TROP2-ADC Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global TROP2-ADC Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of TROP2-ADC Drug include AstraZeneca, BiOneCure Therapeutics, Chiome Bioscience, Gilead, LegoChem Biosciences, Merck, Duoxi Biotech, Kelun Biotech and Shijian Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global TROP2-ADC Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of TROP2-ADC Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents TROP2-ADC Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the TROP2-ADC Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

TROP2-ADC Drug Segment by Company

AstraZeneca

BiOneCure Therapeutics

Chiome Bioscience

Gilead

LegoChem Biosciences

Merck

Duoxi Biotech

Kelun Biotech

Shijian Biotech

DualityBio

TROP2-ADC Drug Segment by Type

Clinical Drugs

Marketed Drugs

TROP2-ADC Drug Segment by Application

Hematological Tumors

Solid Tumors

TROP2-ADC Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TROP2-ADC Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TROP2-ADC Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TROP2-ADC Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the TROP2-ADC Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of TROP2-ADC Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of TROP2-ADC Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of TROP2-ADC Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. TROP2-ADC Drug Industry Trends Table 2. TROP2-ADC Drug Industry Drivers Table 3. TROP2-ADC Drug Industry Opportunities and Challenges Table 4. TROP2-ADC Drug Industry Restraints Table 5. Global TROP2-ADC Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global TROP2-ADC Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global TROP2-ADC Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global TROP2-ADC Drug Sales Market Share by Manufacturers Table 9. Global TROP2-ADC Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global TROP2-ADC Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global TROP2-ADC Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global TROP2-ADC Drug Manufacturers, Product Type & Application Table 13. Global TROP2-ADC Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global TROP2-ADC Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Clinical Drugs Table 17. Major Manufacturers of Marketed Drugs Table 18. Global TROP2-ADC Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global TROP2-ADC Drug Sales by Type (2021-2026) & (K Units) Table 20. Global TROP2-ADC Drug Sales by Type (2027-2032) & (K Units) Table 21. Global TROP2-ADC Drug Sales Market Share by Type (2021-2026) Table 22. Global TROP2-ADC Drug Sales Market Share by Type (2027-2032) Table 23. Global TROP2-ADC Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global TROP2-ADC Drug Revenue by Type (2021-2026) & (K Units) Table 25. Global TROP2-ADC Drug Revenue by Type (2027-2032) & (K Units) Table 26. Global TROP2-ADC Drug Revenue Market Share by Type (2021-2026) Table 27. Global TROP2-ADC Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hematological Tumors Table 29. Major Manufacturers of Solid Tumors Table 30. Global TROP2-ADC Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global TROP2-ADC Drug Sales by Application (2021-2026) & (K Units) Table 32. Global TROP2-ADC Drug Sales by Application (2027-2032) & (K Units) Table 33. Global TROP2-ADC Drug Sales Market Share by Application (2021-2026) Table 34. Global TROP2-ADC Drug Sales Market Share by Application (2027-2032) Table 35. Global TROP2-ADC Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global TROP2-ADC Drug Revenue by Application (2021-2026) & (K Units) Table 37. Global TROP2-ADC Drug Revenue by Application (2027-2032) & (K Units) Table 38. Global TROP2-ADC Drug Revenue Market Share by Application (2021-2026) Table 39. Global TROP2-ADC Drug Revenue Market Share by Application (2027-2032) Table 40. Global TROP2-ADC Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global TROP2-ADC Drug Sales by Region (2021-2026) & (K Units) Table 42. Global TROP2-ADC Drug Sales Market Share by Region (2021-2026) Table 43. Global TROP2-ADC Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global TROP2-ADC Drug Sales Forecasted Market Share by Region (2027-2032) Table 45. North America TROP2-ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 47. North America TROP2-ADC Drug Sales by Country (2027-2032) & (K Units) Table 48. Europe TROP2-ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 50. Europe TROP2-ADC Drug Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific TROP2-ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific TROP2-ADC Drug Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa TROP2-ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa TROP2-ADC Drug Sales by Country (2027-2032) & (K Units) Table 57. Global TROP2-ADC Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global TROP2-ADC Drug Revenue by Region (2021-2026) & (US$ Million) Table 59. Global TROP2-ADC Drug Revenue by Region (2027-2032) & (US$ Million) Table 60. Global TROP2-ADC Drug Revenue Market Share by Region (2021-2026) Table 61. Global TROP2-ADC Drug Revenue Market Share by Region (2027-2032) Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. AstraZeneca TROP2-ADC Drug Product Portfolio Table 66. AstraZeneca Recent Development Table 67. BiOneCure Therapeutics Company Information Table 68. BiOneCure Therapeutics Business Overview Table 69. BiOneCure Therapeutics TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. BiOneCure Therapeutics TROP2-ADC Drug Product Portfolio Table 71. BiOneCure Therapeutics Recent Development Table 72. Chiome Bioscience Company Information Table 73. Chiome Bioscience Business Overview Table 74. Chiome Bioscience TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Chiome Bioscience TROP2-ADC Drug Product Portfolio Table 76. Chiome Bioscience Recent Development Table 77. Gilead Company Information Table 78. Gilead Business Overview Table 79. Gilead TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Gilead TROP2-ADC Drug Product Portfolio Table 81. Gilead Recent Development Table 82. LegoChem Biosciences Company Information Table 83. LegoChem Biosciences Business Overview Table 84. LegoChem Biosciences TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. LegoChem Biosciences TROP2-ADC Drug Product Portfolio Table 86. LegoChem Biosciences Recent Development Table 87. Merck Company Information Table 88. Merck Business Overview Table 89. Merck TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Merck TROP2-ADC Drug Product Portfolio Table 91. Merck Recent Development Table 92. Duoxi Biotech Company Information Table 93. Duoxi Biotech Business Overview Table 94. Duoxi Biotech TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Duoxi Biotech TROP2-ADC Drug Product Portfolio Table 96. Duoxi Biotech Recent Development Table 97. Kelun Biotech Company Information Table 98. Kelun Biotech Business Overview Table 99. Kelun Biotech TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Kelun Biotech TROP2-ADC Drug Product Portfolio Table 101. Kelun Biotech Recent Development Table 102. Shijian Biotech Company Information Table 103. Shijian Biotech Business Overview Table 104. Shijian Biotech TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Shijian Biotech TROP2-ADC Drug Product Portfolio Table 106. Shijian Biotech Recent Development Table 107. DualityBio Company Information Table 108. DualityBio Business Overview Table 109. DualityBio TROP2-ADC Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. DualityBio TROP2-ADC Drug Product Portfolio Table 111. DualityBio Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. TROP2-ADC Drug Distributors List Table 115. TROP2-ADC Drug Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. TROP2-ADC Drug Product Image Figure 2. Global TROP2-ADC Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TROP2-ADC Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global TROP2-ADC Drug Sales (2021-2032) & (K Units) Figure 5. Global TROP2-ADC Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 TROP2-ADC Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Clinical Drugs Image Figure 9. Marketed Drugs Image Figure 10. Global TROP2-ADC Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global TROP2-ADC Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global TROP2-ADC Drug Sales Market Share by Type (2021-2032) Figure 13. Global TROP2-ADC Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global TROP2-ADC Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global TROP2-ADC Drug Revenue Market Share by Type (2021-2032) Figure 16. Hematological Tumors Image Figure 17. Solid Tumors Image Figure 18. Global TROP2-ADC Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global TROP2-ADC Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global TROP2-ADC Drug Sales Market Share by Application (2021-2032) Figure 21. Global TROP2-ADC Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global TROP2-ADC Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global TROP2-ADC Drug Revenue Market Share by Application (2021-2032) Figure 24. North America TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America TROP2-ADC Drug Sales Market Share by Country (2021-2032) Figure 26. U.S. TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe TROP2-ADC Drug Sales Market Share by Country (2021-2032) Figure 31. Germany TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific TROP2-ADC Drug Sales Market Share by Country (2021-2032) Figure 38. China TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa TROP2-ADC Drug Sales Market Share by Country (2021-2032) Figure 46. Brazil TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile TROP2-ADC Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global TROP2-ADC Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global TROP2-ADC Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America TROP2-ADC Drug Revenue (2021-2032) & (US$ Million) Figure 57. North America TROP2-ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe TROP2-ADC Drug Revenue (2021-2032) & (US$ Million) Figure 59. Europe TROP2-ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific TROP2-ADC Drug Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific TROP2-ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa TROP2-ADC Drug Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa TROP2-ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. TROP2-ADC Drug Value Chain Figure 65. Manufacturing Cost Structure Figure 66. TROP2-ADC Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical Drugs
  • Marketed Drugs
Applications
  • Hematological Tumors
  • Solid Tumors
Companies covered
  • AstraZeneca
  • BiOneCure Therapeutics
  • Chiome Bioscience
  • Gilead
  • LegoChem Biosciences
  • Merck
  • Duoxi Biotech
  • Kelun Biotech
  • Shijian Biotech
  • DualityBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global TROP2-ADC Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global TROP2-ADC Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global TROP2-ADC Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global TROP2-ADC Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global TROP2-ADC Drug Market Dynamics
  1. 2.1 TROP2-ADC Drug Industry Trends
  2. 2.2 TROP2-ADC Drug Industry Drivers
  3. 2.3 TROP2-ADC Drug Industry Opportunities and Challenges
  4. 2.4 TROP2-ADC Drug Industry Restraints
3 TROP2-ADC Drug Market by Manufacturers
  1. 3.1 Global TROP2-ADC Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global TROP2-ADC Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global TROP2-ADC Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global TROP2-ADC Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global TROP2-ADC Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global TROP2-ADC Drug Manufacturers, Product Type & Application
  7. 3.7 Global TROP2-ADC Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global TROP2-ADC Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 TROP2-ADC Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 TROP2-ADC Drug Tier 1, Tier 2, and Tier 3
4 TROP2-ADC Drug Market by Type
  1. 4.1 TROP2-ADC Drug Type Introduction
  2. 4.1.1 Clinical Drugs
  3. 4.1.2 Marketed Drugs
  4. 4.2 Global TROP2-ADC Drug Sales by Type
  5. 4.2.1 Global TROP2-ADC Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global TROP2-ADC Drug Sales by Type (2021-2032)
  7. 4.2.3 Global TROP2-ADC Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global TROP2-ADC Drug Revenue by Type
  9. 4.3.1 Global TROP2-ADC Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global TROP2-ADC Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global TROP2-ADC Drug Revenue Market Share by Type (2021-2032)
5 TROP2-ADC Drug Market by Application
  1. 5.1 TROP2-ADC Drug Application Introduction
  2. 5.1.1 Hematological Tumors
  3. 5.1.2 Solid Tumors
  4. 5.2 Global TROP2-ADC Drug Sales by Application
  5. 5.2.1 Global TROP2-ADC Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global TROP2-ADC Drug Sales by Application (2021-2032)
  7. 5.2.3 Global TROP2-ADC Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global TROP2-ADC Drug Revenue by Application
  9. 5.3.1 Global TROP2-ADC Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global TROP2-ADC Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global TROP2-ADC Drug Revenue Market Share by Application (2021-2032)
6 Global TROP2-ADC Drug Sales by Region
  1. 6.1 Global TROP2-ADC Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global TROP2-ADC Drug Sales by Region (2021-2032)
  3. 6.2.1 Global TROP2-ADC Drug Sales by Region (2021-2026)
  4. 6.2.2 Global TROP2-ADC Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America TROP2-ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America TROP2-ADC Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe TROP2-ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe TROP2-ADC Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific TROP2-ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific TROP2-ADC Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa TROP2-ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa TROP2-ADC Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global TROP2-ADC Drug Revenue by Region
  1. 7.1 Global TROP2-ADC Drug Revenue by Region
  2. 7.1.1 Global TROP2-ADC Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global TROP2-ADC Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global TROP2-ADC Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global TROP2-ADC Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America TROP2-ADC Drug Revenue (2021-2032)
  8. 7.2.2 North America TROP2-ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe TROP2-ADC Drug Revenue (2021-2032)
  11. 7.3.2 Europe TROP2-ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific TROP2-ADC Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific TROP2-ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa TROP2-ADC Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa TROP2-ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca TROP2-ADC Drug Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 BiOneCure Therapeutics
  8. 8.2.1 BiOneCure Therapeutics Company Information
  9. 8.2.2 BiOneCure Therapeutics Business Overview
  10. 8.2.3 BiOneCure Therapeutics TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BiOneCure Therapeutics TROP2-ADC Drug Product Portfolio
  12. 8.2.5 BiOneCure Therapeutics Recent Developments
  13. 8.3 Chiome Bioscience
  14. 8.3.1 Chiome Bioscience Company Information
  15. 8.3.2 Chiome Bioscience Business Overview
  16. 8.3.3 Chiome Bioscience TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chiome Bioscience TROP2-ADC Drug Product Portfolio
  18. 8.3.5 Chiome Bioscience Recent Developments
  19. 8.4 Gilead
  20. 8.4.1 Gilead Company Information
  21. 8.4.2 Gilead Business Overview
  22. 8.4.3 Gilead TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Gilead TROP2-ADC Drug Product Portfolio
  24. 8.4.5 Gilead Recent Developments
  25. 8.5 LegoChem Biosciences
  26. 8.5.1 LegoChem Biosciences Company Information
  27. 8.5.2 LegoChem Biosciences Business Overview
  28. 8.5.3 LegoChem Biosciences TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 LegoChem Biosciences TROP2-ADC Drug Product Portfolio
  30. 8.5.5 LegoChem Biosciences Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck TROP2-ADC Drug Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Duoxi Biotech
  38. 8.7.1 Duoxi Biotech Company Information
  39. 8.7.2 Duoxi Biotech Business Overview
  40. 8.7.3 Duoxi Biotech TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Duoxi Biotech TROP2-ADC Drug Product Portfolio
  42. 8.7.5 Duoxi Biotech Recent Developments
  43. 8.8 Kelun Biotech
  44. 8.8.1 Kelun Biotech Company Information
  45. 8.8.2 Kelun Biotech Business Overview
  46. 8.8.3 Kelun Biotech TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kelun Biotech TROP2-ADC Drug Product Portfolio
  48. 8.8.5 Kelun Biotech Recent Developments
  49. 8.9 Shijian Biotech
  50. 8.9.1 Shijian Biotech Company Information
  51. 8.9.2 Shijian Biotech Business Overview
  52. 8.9.3 Shijian Biotech TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shijian Biotech TROP2-ADC Drug Product Portfolio
  54. 8.9.5 Shijian Biotech Recent Developments
  55. 8.10 DualityBio
  56. 8.10.1 DualityBio Company Information
  57. 8.10.2 DualityBio Business Overview
  58. 8.10.3 DualityBio TROP2-ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 DualityBio TROP2-ADC Drug Product Portfolio
  60. 8.10.5 DualityBio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 TROP2-ADC Drug Value Chain Analysis
  2. 9.1.1 TROP2-ADC Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 TROP2-ADC Drug Production Mode & Process
  6. 9.2 TROP2-ADC Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 TROP2-ADC Drug Distributors
  9. 9.2.3 TROP2-ADC Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst